Infections in obstetrics refer to microbial infections that can affect pregnant individuals, the developing fetus, and the newborn during the perinatal period. These infections can have significant consequences for maternal and fetal health, potentially leading to complications such as preterm birth, low birth weight, and long-term developmental issues. Common infections in obstetrics include urinary tract infections, bacterial vaginosis, and sexually transmitted infections (STIs) such as syphilis and chlamydia. These infections may increase the risk of adverse pregnancy outcomes and necessitate prompt and appropriate treatment to safeguard maternal and fetal well-being. Certain viruses, like cytomegalovirus (CMV) and herpes simplex virus (HSV), can be vertically transmitted from mother to baby during pregnancy or childbirth, leading to congenital infections or neonatal infections. Preventive measures, including prenatal screenings, vaccinations, and safe sexual practices, play a crucial role in minimizing the risk of infections during pregnancy. Timely diagnosis and treatment of infections in obstetrics are essential components of prenatal care, ensuring optimal outcomes for both the mother and the newborn. Collaborative efforts between healthcare providers and expectant individuals are fundamental in managing and preventing infections in the field of obstetrics.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India